Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin Quality of Life Study
NCT00367276Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2002
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of drospirenone in contraception, sponsored by Bayer. Primary endpoint: Change of Psychological General Well Being Questionnaire score at 24 weeks. Started Dec 2002; status: completed.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00367276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367276.